Kevin Joseph Fitzgerald - 13 Feb 2025 Form 4 Insider Report for ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Signature
By: Brett Budzinski, Attorney-in-Fact For: Kevin Fitzgerald
Issuer symbol
ALNY
Transactions as of
13 Feb 2025
Net transactions value
-$531,448
Form type
4
Filing time
18 Feb 2025, 16:47:38 UTC
Previous filing
16 Dec 2024
Next filing
18 Jun 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALNY Common Stock Award $0 +2,103 +16% $0.000000 14,984 13 Feb 2025 Direct F1
transaction ALNY Common Stock Sale $36,612 -145 -0.97% $252.50 14,839 14 Feb 2025 Direct F2, F3
transaction ALNY Common Stock Sale $41,553 -164 -1.1% $253.37 14,675 14 Feb 2025 Direct F2, F4
transaction ALNY Common Stock Sale $27,978 -110 -0.75% $254.35 14,565 14 Feb 2025 Direct F2, F5
transaction ALNY Common Stock Sale $12,011 -47 -0.32% $255.56 14,518 14 Feb 2025 Direct F2, F6
transaction ALNY Common Stock Sale $13,583 -53 -0.37% $256.29 14,465 14 Feb 2025 Direct F2, F7
transaction ALNY Common Stock Sale $6,695 -26 -0.18% $257.51 14,439 14 Feb 2025 Direct F2, F8
transaction ALNY Common Stock Sale $8,516 -33 -0.23% $258.07 14,406 14 Feb 2025 Direct F2, F9
transaction ALNY Common Stock Sale $3,117 -12 -0.08% $259.72 14,394 14 Feb 2025 Direct F2, F10
transaction ALNY Common Stock Sale $5,472 -21 -0.15% $260.57 14,373 14 Feb 2025 Direct F2, F11
transaction ALNY Common Stock Sale $6,798 -26 -0.18% $261.45 14,347 14 Feb 2025 Direct F2, F12
transaction ALNY Common Stock Sale $3,160 -12 -0.08% $263.33 14,335 14 Feb 2025 Direct F2
transaction ALNY Common Stock Sale $3,708 -14 -0.1% $264.87 14,321 14 Feb 2025 Direct F2
transaction ALNY Common Stock Sale $271,728 -1,086 -7.6% $250.21 13,235 18 Feb 2025 Direct F13, F14
transaction ALNY Common Stock Sale $28,934 -115 -0.87% $251.60 13,120 18 Feb 2025 Direct F13
transaction ALNY Common Stock Sale $20,484 -80 -0.61% $256.05 13,040 18 Feb 2025 Direct F13, F15
transaction ALNY Common Stock Sale $19,592 -76 -0.58% $257.79 12,964 18 Feb 2025 Direct F13
transaction ALNY Common Stock Sale $21,505 -83 -0.64% $259.10 12,881 18 Feb 2025 Direct F13
holding ALNY Common Stock 537 13 Feb 2025 by Managed Account F16
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 On February 24, 2021, the reporting person was granted a performance-based stock unit (PSU) under the 2018 Stock Incentive Plan. The shares subject to the PSU vest based on the achievement of four specified performance measures. The shares reported were issued to the reporting person upon vesting of one-quarter of the shares subject to the PSU based on the issuer publicly reporting achievement, on or before December 31, 2025, of non-GAAP operating income profitability for a 12-month calendar year, as determined by The People, Culture and Compensation Committee of the Issuer Board of Directors on February 13, 2025.
F2 Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form.
F3 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $251.89 to $252.89. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F4 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $252.90 to $253.89. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F5 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $253.96 to $254.93. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F6 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $254.99 to $255.97. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F7 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $256.01 to $256.84. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F8 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $257.05 to $257.78. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F9 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $257.86 to $258.44. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F10 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $259.21 to $260.14. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F11 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $260.31 to $260.96. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F12 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $261.42 to $261.47. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F13 This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 10, 2024.
F14 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $249.81 to $250.65. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F15 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $256.00 to $256.95. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F16 Reflects shares of ALNY common stock acquired by the Reporting Person under the issuer 401(k) plan as a result of the issuer 401(k) matching contribution program.